The tumor-infiltrating T-cells, as well as CAR gene-modified effectors, also play an important role in providing response to EwS cells, which upregulates HLA-G expression, suggesting the higher efficacy of cellular immunotherapies in EwS (Table 1)[17], [18]. This evidence concerns the gene HLA-G and neoplasm.